Markets
EW

Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst Blog

A generic image of a person with a pen in hand
Credit: Shutterstock photo

Masimo Corporation ( MASI ) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) as well as CE Mark approval for its ISA OR+ multigas monitoring module. Following the approvals, the company announced a global launch of the module.

ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform. The device supports anesthesia agent identification and ventilation management.

During general anesthesia, the ISA OR+ supervises the inhaled and exhaled concentration of five anesthetic gas agents, carbon dioxide, nitrous oxide and oxygen, apart from the respiration rate. Masimo's latest Root module is appropriate for monitoring adult, pediatric or infant patients in a range of clinical environments including the operating room and intensive care unit.

The Root patient monitoring and connectivity platform integrates Masimo's parameters in an integrated, clinician-centric platform. When technology modules are connected with Root, multiple additional parameters are available including Masimo SET pulse oximetry, noninvasive and continuous hemoglobin (SpHb), PVI, SedLine brain function monitoring, and O3 Regional Oximetry.

Masimo's lightweight Radius-7 monitor, which is designed to monitor patients while allowing them freedom of movement, was cleared by the FDA earlier this month. With Masimo's Radius-7 wireless monitor and multiple connectivity options, Root integrates multiple streams of data and simplifies patient care workflows, empowering caregivers to help make quicker patient assessments, earlier interventions and better clinical decisions.

The Root platform is also designed for third-party measurement expansion to allow other companies to expand the platform with their own measurements through MOC-9, following Masimo's established development and validation process.

However, the monitoring products market remains quite competitive with a lot of companies vying for substantial market share. Masimo faces stiff competition from Covidien ( COV ).

Currently, Masimo carries a Zacks Rank #3 (Hold).

Better-ranked medical instruments makers include Edwards Lifesciences Corp. ( EW ) and Globus Medical Inc. ( GMED ). Both these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

MASIMO CORP (MASI): Free Stock Analysis Report

COVIDIEN PLC (COV): Free Stock Analysis Report

EDWARDS LIFESCI (EW): Free Stock Analysis Report

GLOBUS MEDICAL (GMED): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EW MASI GMED

Other Topics

Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More